Iveena Delivery Systems, a Salt Lake City-based biotech, was awarded a $225,000 grant from the National Eye Institute to expand their research into a topical treatment for keratoconus. Dr. Bala Ambati, MD wondered if there might be a way to formulate an eye-drop that would have the same effect as corneal crosslinking. The result, he reasoned, would be a non-invasive, relatively cost effective, topical therapy for treatment of keratoconus.